SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-014280
Filing Date
2022-08-03
Accepted
2022-08-03 16:22:24
Documents
70
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rcus-20220630.htm   iXBRL 10-Q 2850877
2 EX-10.2 rcus-ex10_2.htm EX-10.2 60439
3 EX-31.1 rcus-ex31_1.htm EX-31.1 18637
4 EX-31.2 rcus-ex31_2.htm EX-31.2 18685
5 EX-32.1 rcus-ex32_1.htm EX-32.1 11072
6 EX-32.2 rcus-ex32_2.htm EX-32.2 11098
  Complete submission text file 0000950170-22-014280.txt   9643762

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rcus-20220630_lab.xml EX-101.LAB 463548
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rcus-20220630_pre.xml EX-101.PRE 334968
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rcus-20220630.xsd EX-101.SCH 72435
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rcus-20220630_cal.xml EX-101.CAL 49318
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rcus-20220630_def.xml EX-101.DEF 197906
64 EXTRACTED XBRL INSTANCE DOCUMENT rcus-20220630_htm.xml XML 1783241
Mailing Address 3928 POINT EDEN WAY HAYWARD CA 94545
Business Address 3928 POINT EDEN WAY HAYWARD CA 94545 (510) 694-6200
Arcus Biosciences, Inc. (Filer) CIK: 0001724521 (see all company filings)

IRS No.: 473898435 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38419 | Film No.: 221132971
SIC: 2834 Pharmaceutical Preparations